openPR Logo
Press release

Joint Health Supplement

07-20-2011 08:23 AM CET | Health & Medicine

Press release from: enovatebiolife

Salt Lake City, Utah (July 19, 2011) – ENovate Biolife LLC, announced the launch of its clinically documented supplement for joint health ‘Lanconone’. Lanconone is popular worldwide and is now available online in the US. Lanconone is an all natural formula tested to deliver greater joint flexibility and facilitate walking, bending, climbing, gardening and other everyday activities. Lanconone is manufactured under Gold standards using standardized ingredients to give fast and sustained relief in quickest possible time.
“We aim to meet the industry demands on science driven quality products and this is the first step towards meeting our strategic goals,” says Jayesh Chaudhary, CEO of ENovate Biolife LLC.

The published study has revealed that taking Lanconone supplement can significantly improve joint stiffness and mobility. The study results suggest that taking Lanconone can provide 46% improvement in walking and bending activities compared to 19% improvement in subjects taking placebo. Similarly 41% improvement was noted in stabilizing joint mobility and in overall joint health with Lanconone as compared to 16% in subjects taking placebo. Breaking away from the conflicting evidence of the effectiveness of Glucosamine, Lanconone distinctly provides quicker relief and prolonged effect. It is also free from major food allergens. A daily dosage of two capsules supports ongoing joint health and joint mobility for the future.

Lanconone is available through online purchase at www.lanconone.com Delivered within 7 days from date of purchase and comes with 5 Star*****Guarantee.
About ENovate Biolife

ENovate Biolife LLC discovers and develops novel multi-mechanism / multi-component Botanical Drugs and Healthcare Products. A focused scientific development strategy helps to reduce research and development cost and time without compromising on safety and efficacy.

To get a full review of Lanconone please visit www.lanconone.com

Contact us at:
ENOVATE BIOLIFE LLC. www.enovatebiolife.com, bizdev@enovatebiolife.com

ENovate Biolife Discovers and Develops novel multi-mechanism / multi-component Botanical Drugs and Healthcare Products. Our focused Scientific Development Strategy helps to reduce Research and Development Cost and Time without compromising on Safety and Efficacy. As a Phyotmedicine innovator, we are committed to improving the health and quality of life of patients.

203, Morya Landmark 1,Off New Link Road,
Andheri West,
Mumbai - 400053
Ph No: +91 22 42172300
Fax No: +91 22 66941179
Email ID - bizdev@enovatebiolife.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Joint Health Supplement here

News-ID: 184038 • Views: 1181

More Releases from enovatebiolife

ENovate Biolife Targets African Market
Salt Lake City, Utah (Sept 10, 2011) – ENovate Biolife LLC is pleased to announce their participation at Medexpo Kenya 2011 at Nairobi. The Medexpo Kenya will take place on 17-19 September 2011 at Sarit Centre. Medexpo Kenya is the prime event in the region attracting visitors from all over East & Central Africa displaying vast range of products from Hospital Supplies, Medical Equipment, Dental Equipment, Healthcare supplements and Pharmaceuticals.
ENovate Biolife announces start of Clinical Study for Rhinitis
For Immediate Release California, July 20, 2011: ENovate Biolife, a specialty healthcare company, announced today that it has initiated a Phase IIa clinical trial with its lead product E-RH-06 in subjects with Rhinitis. ENovate Biolife has received ethics committee approval for safety and dose determining study for investigational product E-RH-06 for the metabolic management of chronic or recurrent, non-infective nasal congestion with-or-without rhinorrhea. Rhinitis (allergic or non allergic) is a clinical problem
Enovate Biolife enters the Filipino Supplement Market
Enovate Biolife signed a collaboration agreement with Manila-based MP-AIMM Marketing Corporation to enter the Philippines Supplements Market. For Immediate Release Redwood City, CA, June 15, 2011: The research products of Enovate Biolife will be now available in Philippines through the distribution channel of MP-AIMM Marketing Corporation. The company has tied-up with AIMM, marketing various products and services with distribution networks all over the country. “We are pleased to partner with
ENovate Biolife Targets Asia-Pacific Markets
Salt Lake City, Utah (July 20, 2011) – ENovate Biolife LLC is pleased to announce their participation at Natural Products Expo Asia 2011 in Hong Kong. The 9th Natural Products Expo Asia (www.naturalproductsasia.com) will take place at the Hong Kong Convention and Exhibition Centre on 25 – 27 August 2011. It is the premier sourcing trade show for Asia’s natural, organic and healthy products industry, attracting over 350 exhibitors and

All 5 Releases